Pozitsii i kombinatsii lerkanidipina i enalaprila v sootvetstvii s rekomendatsiyami po arterial'noy gipertenzii-2013
- Autores: Fomin V.V1
-
Afiliações:
- Edição: Nº 20 (2013)
- Páginas: 80-83
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286517
- ID: 286517
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The recommendations of the European Society of Hypertension 2013 kept the focus on the use of fixed combinations of antihypertensive drugs. Special attention is paid to the choice of antihypertensive drugs in the different clinical situations taking into account the evidence base. From this point of view, angiotensin-converting enzyme inhibitors with calcium antagonists can be as regarded one of the most preferred combinations. The results of clinical studies that used a combination of lercanidipine and enalapril are discussed.
Texto integral
Bibliografia
- The ESH-ESC Task Force for the management of arterial hypertension. 2013 ESH/ESC Guidelines for the management of arterial hypertension // J. Hypertens. -2013. - Vol. 31. -P. 1285-357.
- Dahlof B., Sever P., Poulter N.R., et al, ASCOT Investigators. Prevention of cardiovascular events with antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendoflumethiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial // Lancet. -2005. - Vol. 366. - P. 895-906.
- Jameson K., Weber M.A, Bakris G.L, et al., ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients // N. Engl. J. Med. - 2008. - Vol. 359. - P. 2417-28.
- Dougall H.T, McLay J. A comparative review of the adverse events of calcium antagonists // Drug Saf. - 1996. - Vol. 15(2). - P. 91-106.
- Romito R, Pansini M.I., Perticone F., et al. Comparative effect of lercanidipine, felodipine, and nifedipine GITS on blood pressure and heart rate in patients with mild to moderate arterial hypertension: the Lercanidipine in Adults (LEAD) Study // J. Clin. Hypertens (Greenwich). -2003. - Vol. 5(4). - P. 249-53.
- Lund-Johansen P., Stranden E., Helberg S., et al. Quantification of leg oedema in postmenopausal hypertensive patients treated with lercanidipine or amlodipine // J. Hypertens. - 2003. - Vol. 21(5). - P. 1003-10.
- Hair P.I., Scott L.J., Perry C.M. Fixed-dose combination lercarnidipine/enalapril // Drugs. - 2007. - Vol. 67. - P. 95-106.
- Todd P.A., Goa K.L. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension // Drugs. - 1992. - Vol. 43. - P. 346-81.
- Estacio R.O., Schreier R.W. Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial // Am. J. Cardiol. 1998. -Vol. 2. - R1-R4.
- Agarwal R., Marx A., Haller H. Efficacy and safety of lercarnidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension // J. Hypertens. - 2006. - Vol. 24. - P. 185-92.
- Scholze J., Bramlage P., Trenkwalder P., Kreutz R. Efficacy and safety of a fixed-dose combination of lercanidipine and enalapril in daily practice. A comparison of office, self-measured and ambulatory blood pressure // Expert Opin. Pharmacother. - 2011. - Vol. 12(18). -P. 2771-79.
- Egan C.G., Pontremoli R. Role of the fixed-dose combination lercanidipine-enalapril in renal protection // J. Nephrol. - 2011. - Vol. 24(4). -P. 428-37.
- Puig J.G., Calvo C., Luurila O., et al. Lercarnidipine, enalapril and their combination in the treatment of elderly hypertensive patients; placebocontrolled, randomized, crossover study with four ABPM // J. Hum Hypertens. - 2007. -Vol. 21. - P. 917-24.
- Rump L.C. Efficacy and tolerability of the fixed lercarnidipine-enalapril combination in the treatment of patients with essential hypertension // Arzneimittelforschung. - 2010. - Vol. 60. -P. 124-30.
Arquivos suplementares
